Literature DB >> 8686525

Immune infiltrates and cytokines in gliomas.

B Giometto1, F Bozza, F Faresin, L Alessio, S Mingrino, B Tavolato.   

Abstract

Frozen sections of 21 gliomas were analysed to characterize inflammatory infiltrating cells, HLA-DR antigen expression and cytokine secretion. Mononuclear cells infiltrating the tumours were mostly macrophages, which were detected in 100% of cases, and expressed HLA-DR antigens. Lymphocytes were less frequently seen and expressed the CD8 phenotype. Interleukin-1 beta (IL-1 beta) and Interleukin-6 (IL-6), two cytokines mainly produced by activated cells of the macrophage lineage, were demonstrated especially in neoplastic astrocytes. IL-1 beta immunoreactivity was detected in all tumours, and was prevalent in more anaplastic gliomas; IL-6 was found in anaplastic gliomas and in glioblastomas. IL-1 receptors were expressed by both infiltrating macrophages and neoplastic astrocytes in the gliomas analysed. These findings suggest that cytokine production in gliomas seems not related to immune reactions against the tumour and their synthesis by anaplastic astrocytes could follow an unregulated activation of many metabolic processes after neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8686525     DOI: 10.1007/bf01411724

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  34 in total

1.  Transferrin receptors in rat central nervous system. An immunocytochemical study.

Authors:  B Giometto; F Bozza; V Argentiero; P Gallo; S Pagni; M G Piccinno; B Tavolato
Journal:  J Neurol Sci       Date:  1990-08       Impact factor: 3.181

2.  Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation.

Authors:  T Morimura; C Neuchrist; K Kitz; H Budka; O Scheiner; D Kraft; H Lassmann
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Immunohistological study of mononuclear cell infiltrate in malignant gliomas.

Authors:  M L Rossi; J T Hughes; M M Esiri; H B Coakham; D B Brownell
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Brain tumors: detection of B-cell stimulatory factor-2/interleukin-6 in the absence of oligoclonal bands of immunoglobulins.

Authors:  D Leppert; K Frei; P Gallo; M G Yasargil; K Hess; G Baumgartner; A Fontana
Journal:  J Neuroimmunol       Date:  1989-10       Impact factor: 3.478

5.  Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 1. Gliomas.

Authors:  C S Morris; M M Esiri
Journal:  J Neurol Sci       Date:  1991-01       Impact factor: 3.181

6.  Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema.

Authors:  M Shinonaga; C C Chang; N Suzuki; M Sato; T Kuwabara
Journal:  J Neurosurg       Date:  1988-02       Impact factor: 5.115

7.  Interleukin-1 stimulation of astroglial proliferation after brain injury.

Authors:  D Giulian; L B Lachman
Journal:  Science       Date:  1985-04-26       Impact factor: 47.728

8.  In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers.

Authors:  S Miescher; T L Whiteside; N de Tribolet; V von Fliedner
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

9.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].

Authors:  D Schiffer; G Croveri; C Pautasso
Journal:  Tumori       Date:  1974 May-Jun
View more
  24 in total

1.  An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

Authors:  Abdeljabar El Andaloussi; Maciej S Lesniak
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

2.  Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation.

Authors:  Tim Kees; Jennifer Lohr; Johannes Noack; Rodrigo Mora; Georg Gdynia; Grischa Tödt; Aurélie Ernst; Bernhard Radlwimmer; Christine S Falk; Christel Herold-Mende; Anne Régnier-Vigouroux
Journal:  Neuro Oncol       Date:  2011-10-20       Impact factor: 12.300

3.  Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion.

Authors:  Katyayni Vinnakota; Feng Hu; Min-Chi Ku; Petya B Georgieva; Frank Szulzewsky; Andreas Pohlmann; Sonia Waiczies; Helmar Waiczies; Thoralf Niendorf; Seija Lehnardt; Uwe-Karsten Hanisch; Michael Synowitz; Darko Markovic; Susanne A Wolf; Rainer Glass; Helmut Kettenmann
Journal:  Neuro Oncol       Date:  2013-09-05       Impact factor: 12.300

4.  Presurgical serum albumin levels predict survival time from glioblastoma multiforme.

Authors:  J A Schwartzbaum; P Lal; W Evanoff; S Mamrak; A Yates; G H Barnett; J Goodman; J L Fisher
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 5.  Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.

Authors:  James F Curtin; Gwendalyn D King; Marianela Candolfi; Remy B Greeno; Kurt M Kroeger; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

6.  Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression.

Authors:  Rui Pedro Galvão; Hui Zong
Journal:  Curr Pathobiol Rep       Date:  2013-03-01

7.  Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages.

Authors:  Orin Bloch; Courtney A Crane; Rajwant Kaur; Michael Safaee; Martin J Rutkowski; Andrew T Parsa
Journal:  Clin Cancer Res       Date:  2013-04-23       Impact factor: 12.531

Review 8.  The Dynamics of Interactions Among Immune and Glioblastoma Cells.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2015-07-30       Impact factor: 3.843

Review 9.  Immunotherapeutic approaches for glioma.

Authors:  Hideho Okada; Gary Kohanbash; Xinmei Zhu; Edward R Kastenhuber; Aki Hoji; Ryo Ueda; Mitsugu Fujita
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

Review 10.  Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.

Authors:  Wei Zhou; Zheng Jiang; Xingang Li; Yangyang Xu; Zhenyu Shao
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-09       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.